Adjunctive host-directed therapies for pulmonary tuberculosis: a prospective, open-label, phase 2, randomised controlled trial.

Wallis, Robert S; Ginindza, Sibuse; Beattie, Trevor; Arjun, Nishanee; Likoti, Morongwe; Edward, Vinodh A; Rassool, Mohammed; Ahmed, Khatija; Fielding, Katherine; Ahidjo, Bintou A; +2 more... Vangu, Mboyo DT; Churchyard, Gavin; (2021) Adjunctive host-directed therapies for pulmonary tuberculosis: a prospective, open-label, phase 2, randomised controlled trial. Lancet respiratory medicine, 9 (8). pp. 897-908. ISSN 2213-2600 DOI: https://doi.org/10.1016/S2213-2600(20)30448-3

Permanent Identifier

Use this Digital Object Identifier when citing or linking to this resource.

https://doi.org/10.1016/S2213-2600(20)30448-3

Abstract

Share

Download

Filename: 1-s2.0-S2213260020304483-main.pdf

Licence: Creative Commons: Attribution 4.0

Download
[img]

Downloads

View details

Metrics & Citations


Google Scholar